What are the six tumor markers for women?
The six tumor markers for women include alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA19-9, squamous cell carcinoma antigen (SCC), CA15-3, and CA12-5.
1. Alpha-fetoprotein (AFP)
Elevated AFP levels are primarily associated with primary liver malignancies and germ cell tumors.
2. Carcinoembryonic Antigen (CEA)
This marker lacks high specificity and may be elevated in various cancers, such as gastric cancer, colorectal cancer, pancreatic cancer, and cholangiocarcinoma.
3. CA19-9
Besides pancreatic cancer, elevated CA19-9 can also be seen in mucinous ovarian adenocarcinoma and endometrial cancer. Benign conditions such as pelvic inflammatory disease should also be considered.
4. Squamous Cell Carcinoma Antigen (SCC)
Significantly increased levels are commonly observed in patients with cervical cancer and lung squamous cell carcinoma.
5. CA15-3
In certain serous ovarian cancers, as well as non-malignant conditions affecting the liver, gastrointestinal tract, breast, and ovaries, positivity rates below 10% may occur.
6. CA12-5
This is a marker primarily associated with ovarian cancer in women. Among all these markers, only AFP has high specificity; the others are easily influenced by various non-cancerous factors. If any of these values are abnormal, whole-body imaging (e.g., X-ray or other imaging modalities) should be performed to determine whether a tumor is present.
Once diagnosed, prompt treatment should be initiated to improve the patient's health outcome. Elevated tumor markers are generally not due to inflammatory infections unless specifically related to such conditions.